Latest News about CRSP
Recent news which mentions CRSP
From InvestorPlace
Cathie Wood Continues To Sell Tesla Shares Amid Q2 Deliveries-Induced Strength: Here's How Much Shares Ark Offloaded Monday
July 03, 2023
From Benzinga
Vertex Pharmaceuticals Stock: Bear vs. Bull
July 03, 2023
From Motley Fool
3 Stocks That Every 20-Year-Old Should Buy Today
July 02, 2023
From InvestorPlace
From InvestorPlace
This 1 Problem Could Sink at Least 4 Gene-Editing Stocks
June 29, 2023
From Motley Fool
2 Unstoppable Growth Stocks to Buy in 2023 and Beyond
June 29, 2023
From Motley Fool
2 Under-the-Radar Biotech Stocks to Buy in 2023
June 28, 2023
From Motley Fool
The Best Stocks to Invest $20,000 in Right Now
June 28, 2023
From Motley Fool
Why Shares of Nkarta Are Slumping Tuesday
June 27, 2023
From Motley Fool
Wall Street Estimates That CRISPR Therapeutics Stock Could Jump 49%. Here's Why That's Right.
June 27, 2023
Tickers
CRSP
From Motley Fool
3 Monster Stocks in the Making to Buy Right Now
June 25, 2023
From Motley Fool
Alleged Industrial Espionage Makes an Interesting Story
June 21, 2023
From Motley Fool
Cathie Wood Is Buying This Growth Stock and Selling Its Competitor. Should You Follow Suit?
June 21, 2023
From Motley Fool
Buying This Growth Stock Hand-Over-Fist Right Now Could Make You a Lot Wealthier by 2030
June 21, 2023
From Motley Fool
Is CRISPR Therapeutics Stock a Buy Now?
June 21, 2023
From Motley Fool
From InvestorPlace
From Motley Fool
From Motley Fool
2 Short-Squeeze Candidates That Could Go Parabolic
June 15, 2023
From Motley Fool
This Move Is a First for the FDA. Could It Signal a Big Turning Point for CRISPR Therapeutics?
June 13, 2023
Tickers
CRSP
From Motley Fool
5 Stocks to Buy With Explosive 500% Potential
June 12, 2023
From InvestorPlace
2 Biotech Stocks That Could Help Make You a Fortune
June 12, 2023
From Motley Fool
3 No-Brainer Stocks to Buy in June
June 10, 2023
From Motley Fool
Breakthrough in CRISPR-Based Therapy: FDA Accepts Vertex and CRISPR Therapeutics' Exa-cel Application
June 09, 2023
From Benzinga
Vertex/CRISPR Partnered Cell Therapy Shows Encouraging In Sickle Cell Disease, Thalassemia Patients
June 09, 2023
From Benzinga
From InvestorPlace
TGT Stock Alert: Have Target’s Sales Numbers Peaked?
June 09, 2023
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.